Dan Rossignol

Dan Rossignol is a clinical pharmacologist and board-certified family physician known for his work in the field of autism research and integrative medicine. He holds an MD from the Virginia Commonwealth University School of Medicine and completed his residency in family medicine at the University of Virginia. Rossignol is affiliated with the Rossignol Medical Center, which operates locations in Florida and California, where he treats patients with various neurological and developmental disorders, particularly autism spectrum disorders (ASD) and related conditions.12

Professional Background

• Clinical Focus: Rossignol has a strong emphasis on autism therapies, including hyperbaric oxygen therapy (HBOT), which he has studied extensively. His work includes randomized clinical trials examining the efficacy and safety of such treatments for children with autism.12
• Research Contributions: He has authored over 55 scientific papers, abstracts, and editorials concerning autism and related conditions. His most notable research includes studies on mitochondrial disorders in autistic children and the use of melatonin as a treatment for sleep issues in this population.12

Advocacy and Impact

Rossignol is recognized for his advocacy within the autism community, serving on advisory boards and contributing to discussions about effective treatments. His approach combines traditional medical practices with integrative strategies, aiming to provide comprehensive care for patients with complex medical needs.23

Awards and Recognition

He has received accolades for his research efforts, including the Edgar End Memorial Award from the Undersea and Hyperbaric Medical Society, highlighting his contributions to the field of hyperbaric medicine.1

Overall, Dan Rossignol's work is characterized by a commitment to advancing understanding and treatment options for autism, making him a significant figure in both clinical practice and research within this specialized area.